Literature DB >> 26224037

No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.

YongPing Chen1, XiaoQin Yuan1, Bei Cao1, QianQian Wei1, RuWei Ou1, Jing Yang1, XuePing Chen1, Bi Zhao1, Wei Song1, Ying Wu1, HuiFang Shang2.   

Abstract

Recently, a series of studies found that the single-nucleotide polymorphisms (SNPs) rs6812193 in the family with sequence similarity 47, member E (FAM47E), rs6825004 in the scavenger receptor class B member 2 (SCARB2) and rs4889603 in the Syntaxin1B (STX1B) genes increase the risk for Parkinson's disease (PD). However, the results of subsequent independent studies were inconsistent. To explore the associations between the three SNPs and PD in the Chinese population, a large cohort was analyzed in a case-control study. A total of 1994 subjects, including 1179 PD and 815 healthy controls (HCs), were investigated. All subjects were genotyped for rs6812193, rs6825004 and rs4889603 using the Sequenom iPLEX Assay. There was no significant difference in additive genetic model of rs6812193, rs6825004 and rs4889603 between PD and controls, even after being stratified by sex and age. In addition, no significant differences were found between other subgroups of PD patients with regard to clinical presentation. Our findings suggested that FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 do not confer a significant risk for PD in Chinese population.

Entities:  

Keywords:  Associations; FAM47E; Parkinson’s disease; Polymorphisms; SCARB2; STX1B

Mesh:

Substances:

Year:  2015        PMID: 26224037     DOI: 10.1007/s00702-015-1430-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.

Authors:  Maria G Macedo; Dagmar Verbaan; Yue Fang; Stephanie M van Rooden; Martine Visser; Burcu Anar; Antonella Uras; Justus L Groen; Patrizia Rizzu; Jacobus J van Hilten; Peter Heutink
Journal:  Mov Disord       Date:  2009-01-30       Impact factor: 10.338

2.  Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data.

Authors:  Emerson Maniwang; Nahid Tayebi; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2013-01-29       Impact factor: 4.797

3.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

4.  Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese.

Authors:  Shuai Chen; Yu Zhang; Wei Chen; Ying Wang; Jun Liu; Tian-Yi Rong; Jian-Fang Ma; Gang Wang; Jing Zhang; Jing Pan; Qin Xiao; Sheng-Di Chen
Journal:  Neurosci Lett       Date:  2012-03-23       Impact factor: 3.046

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.

Authors:  Helen Michelakakis; Georgia Xiromerisiou; Efthimios Dardiotis; Maria Bozi; Demetrios Vassilatis; Persa-Maria Kountra; Gianna Patramani; Marina Moraitou; Dimitra Papadimitriou; Eleftherios Stamboulis; Leonidas Stefanis; Elias Zintzaras; Georgios M Hadjigeorgiou
Journal:  Mov Disord       Date:  2012-01-05       Impact factor: 10.338

Review 7.  Description of Parkinson's disease as a clinical syndrome.

Authors:  Stanley Fahn
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

8.  Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease.

Authors:  Lasse Pihlstrøm; Gunnar Axelsson; Kari Anne Bjørnarå; Nil Dizdar; Camilla Fardell; Lars Forsgren; Björn Holmberg; Jan Petter Larsen; Jan Linder; Hans Nissbrandt; Ole-Bjørn Tysnes; Eilert Ohman; Espen Dietrichs; Mathias Toft
Journal:  Neurobiol Aging       Date:  2012-11-13       Impact factor: 4.673

9.  Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.

Authors:  Kallirhoe Kalinderi; Sevasti Bostantjopoulou; Zoe Katsarou; Liana Fidani
Journal:  Neurosci Lett       Date:  2013-03-07       Impact factor: 3.046

10.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

View more
  3 in total

1.  Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan.

Authors:  Kuo-Hsuan Chang; Chiung-Mei Chen; Yi-Chun Chen; Hon-Chung Fung; Yih-Ru Wu
Journal:  Parkinsons Dis       Date:  2019-01-02

2.  Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2.

Authors:  Ria Thomas; Elizabeth B Moloney; Zachary K Macbain; Penelope J Hallett; Ole Isacson
Journal:  Mol Brain       Date:  2021-01-19       Impact factor: 4.041

Review 3.  Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Shani Blumenreich; Or B Barav; Bethan J Jenkins; Anthony H Futerman
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.